Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × Heparin × Clear all

Phase

Status

Terminated 2 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Malignant Female Reproductive System Neoplasm 1

Interventions

Paclitaxel 3 Radiotherapy 2 Oxaliplatin 2 Methotrexate 2 Fluorouracil 2 Doxorubicin 2 Cytarabine 2 Cyclophosphamide 2 titanium silicide 1 pegaspargase 1 exemestane 1 eribulin 1 durvalumab 1 ceralasertib 1 Vincristine 1 Thioguanine 1 Taxes 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 S 1 (combination) 1 Rituximab 1 Prednisolone 1 Passive Cutaneous Anaphylaxis 1 Neoadjuvant Therapy 1 Morphine 1 Methylprednisolone 1 Methadone 1 Mercaptopurine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡